Meros Investment Management, LP Harvard Bioscience Inc Put Options Transaction History
Meros Investment Management, LP
- $164 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HBIO
# of Institutions
86Shares Held
23.2MCall Options Held
8.7KPut Options Held
2K-
Amh Equity LTD3.51MShares$1.86 Million2.13% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.51 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.19MShares$1.16 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$982,5620.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.53MShares$809,7830.05% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $22.1M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...